AERIE PHARMACEUTICALS INC's ticker is and the CUSIP is 00771VAB4. A total of 24 filers reported holding AERIE PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $6,969,000 | -71.1% | 7,118,000 | -75.1% | 0.00% | -62.5% |
| Q2 2022 | $24,135,000 | -6.8% | 28,618,000 | -0.3% | 0.01% | 0.0% |
| Q1 2022 | $25,891,000 | +17.6% | 28,700,000 | +9.5% | 0.01% | +33.3% |
| Q4 2021 | $22,009,000 | -6.5% | 26,200,000 | 0.0% | 0.01% | -25.0% |
| Q3 2021 | $23,547,000 | -8.8% | 26,200,000 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $25,808,000 | -3.8% | 26,200,000 | +0.4% | 0.01% | -11.1% |
| Q1 2021 | $26,830,000 | +19.4% | 26,100,000 | +6.5% | 0.01% | +12.5% |
| Q4 2020 | $22,465,000 | +123.2% | 24,500,000 | +96.0% | 0.01% | +100.0% |
| Q3 2020 | $10,066,000 | – | 12,500,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 157,390,000 | $143,842,000 | 2.81% |
| PFM Health Sciences, LP | 48,150,000 | $44,256,000 | 1.30% |
| DAFNA Capital Management LLC | 1,500,000 | $1,375,000 | 0.36% |
| SILVERBACK ASSET MANAGEMENT LLC | 2,500,000 | $2,303,000 | 0.34% |
| Context Capital Management, LLC | 2,979 | $2,707,000 | 0.28% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 9,667,000 | $8,842,000 | 0.16% |
| DeepCurrents Investment Group LLC | 3,700,000 | $3,423,000 | 0.10% |
| LOOMIS SAYLES & CO L P | 1,249,328 | $14,242,000 | 0.02% |
| SG Americas Securities, LLC | 22,600 | $2,255,000 | 0.01% |
| LAZARD ASSET MANAGEMENT LLC | 9,218,000 | $8,376,000 | 0.01% |